Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Pain in patients with ankylosing spondylitis (AS) may stem from factors other than spinal inflammation, researchers said after discovering that the main subjective factors of disease activity were associated ... Read more
Many ankylosing spondylitis (AS) patients who start treatment with a TNF-blocker switch treatments, use additional medications, or stop the treatment completely within a year, a recent study shows. These ... Read more
CreakyJoints has released a guide for people living with ankylosing spondylitis, the first to be developed by patients and reviewed by rheumatologists. “A Patient’s Guide to Living with Ankylosing ... Read more
Health Canada has approved Sandoz’s Erelzi, a biosimilar therapy of etanercept, for the treatment of ankylosing spondylitis and two other conditions targeted by Amgen’s original therapy Enbrel. Canadian health ... Read more
Pin It on Pinterest